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Abstract
Objective—To estimate the proportion of pregnant women with one or more leiomyoma
detected by research quality ultrasound screening in the first trimester; to describe the size and
location of leiomyomas identified; and to report variation in prevalence by race/ethnicity.
Methods—Within an ongoing prospective cohort we conducted 4,271 first trimester, or post-
miscarriage, ultrasounds. Sonographers measured each leiomyoma three separate times, recording
the maximum diameter in three perpendicular planes each time. Sonographers and investigators
classified type and location.
Results—Among 458 women with one or more leiomyomas (prevalence 10.7%), we identified a
total of 687 leiomyomas. The mean size of the largest leiomyoma was 2.3cm (95% CI 1.8 to 2.8).
Mean gestational age at ultrasound was 61 ± 13 days from last menstrual period. Prevalence
varied by race/ethnicity: 18% in blacks (95%CI: 13, 25); 8% in whites (95%CI: 7, 11); and 10% in
Hispanics (95% CI: 5, 19). The proportion of women with leiomyomas increased with age much
more steeply for blacks than whites.
Conclusions—Leiomyomas are common in pregnancy and occur more often among black
women. Given the limited research on effects of leiomyomas on reproductive outcomes, the
degree to which race/ethnic disparities in prevalence of leiomyomas may contribute to disparities
in events like miscarriage and preterm birth warrants investigation.
INTRODUCTION
Uterine leiomyomata are common and concerning. Leiomyomata have been associated with
adverse pregnancy outcomes including difficulty conceiving, spontaneous abortion, preterm
birth, placental abruption, and cesarean birth (1-8). By age 35 among non-pregnant women,
more than 60% of black women and almost 40% of white women have leiomyomata
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identifiable by imaging (9). Thus, overall prevalence in pregnancy could average 10 to 20%,
with higher prevalence in women of advancing maternal age. Little is known about either
prevalence of leiomyomata or their reproductive risks from prospective studies in pregnant
populations that reflect the general population of the United States (10). Available
information has been gathered in subgroups such as women seeking care for infertility, from
European populations, and from ultrasound databases of academic medical centers (11-15).
Advances in ultrasound have made some prior operational definitions obsolete. The Muram
criteria have been widely used in research to define the presence of a leiomyoma by
ultrasound. The original criteria included visualization of a spherical mass with diameter ≥
3cm; distortion of the adjacent myometrium by the mass; and a distinctive echogenicity,
differentiating the mass from myometrium (16). Improvements in ultrasound resolution
suggest we can now confidently identify and measure smaller leiomyomata. Prior literature
reports prevalence of leiomyomata in pregnancy is less than 1% to 5% (8,14,17-20). A low
prevalence in these studies may result from 1.) operational definitions requiring a large
diameter to define presence of leiomyomata; 2.) inconsistent documentation of leiomyomata
in clinical databases subsequently used for research; 3.) difficulty detecting leiomyomata as
pregnancy progresses and uterine anatomy, fetus, and placenta interfere with complete
assessment of the myometrium; or 4) study populations that are highly selected for younger
women.
Using a prospective study design with community-based recruitment and research quality
ultrasound for all participants, we sought to: 1.) estimate what proportion of women have
leiomyomata ≥0.5cm maximum diameter in the first trimester of pregnancy; 2.) describe the
size, type, and location of leiomyomata identified; and 3.) report any variation by race/
ethnicity.
Materials and Methods
Right from the Start (RFTS) is a prospective, cohort study of pregnancy that includes
women from four metropolitan areas in three states (NC, TN, TX). IRB approval was
obtained from each of four participating academic institutions. Women included in this
analysis were recruited from 2001 to 2007 using multiple approaches including print
materials in community practices, direct home mailings, pregnancy test kit coupons at
pharmacies, newsletters and advertisements (21). The study is described in outreach
materials as a study of early pregnancy health and has never been advertised as a study
about leiomyomata in pregnancy. Women were eligible to participate if they were 18 years
or older, enrolled by 12 6/7 weeks gestation based on last menstrual period (LMP), did not
use assisted reproductive technology, intended to carry the pregnancy to term, spoke English
or Spanish, and did not plan to move for the next 18 months. Women could re-enroll for
subsequent pregnancies, but only first enrollments with ultrasound data on leiomyoma status
were included in this analysis.
The study was designed to enroll women very early in pregnancy. Women who were
planning a pregnancy were “pre-enrolled” for up to six months and were enrolled once they
reported a pregnancy (n=858); the balance enrolled in the first trimester. An abbreviated
interview was done at intake and a more detailed computer-assisted telephone interview was
conducted in the first trimester including extensive reproductive and medical history.
Women self-reported race and ethnicity. This interview also gathered information about
diagnosis and treatment of leiomyomata prior to the current pregnancy.
Endovaginal ultrasound without Doppler (supplemented if needed by trans-abdominal
images), was scheduled for all participants aiming for the beginning of the sixth week of
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gestation. Beginning in January 2005, participants who reported a pregnancy loss prior to
the scheduled ultrasound were also invited to have an ultrasound; this was scheduled within
two weeks of their report (n=56). Sonographers at each study site were required to have
three or more years of clinical obstetric-gynecologic experience. They received additional
research training on uniformity in identifying and measuring leiomyomata and were
instructed not to discuss leiomyoma history with participants.
Presence of a leiomyoma was defined by the Muram criteria with modification to include
masses of maximum diameter ≥0.5cm (16). When a leiomyoma was identified, the diameter
was measured in three perpendicular planes. During the ultrasound, sonographers returned
twice more to each leiomyoma to record the same measurements. (Intervening time was
used to record gestational structures). Triplicate measures were intended to reduce the
chance that focal contractions would be misclassified as leiomyomata. Leiomyoma
diameters were averaged across all three measures and a mean diameter was calculated for
each leiomyoma. We refer to mean diameter of the largest leiomyoma when we use the term
leiomyoma size.
Leiomyomata were “mapped” onto a uterine diagram and were categorized by location
(fundus, corpus, lower segment), position (anterior, posterior, right and left), and type. Type
was defined in mutually exclusive categories: submucous – any leiomyoma in contact with
or distorting the uterine cavity without identifiable myometrium between the leiomyoma and
the endometrium; subserous – distorting the external contour of the uterus; intramural –
within the myometrium, neither distorting contour nor cavity; and pedunculated – attached
to the uterus with an identifiable stalk. Women with multiple leiomyomata had each
leiomyoma documented separately. Leiomyoma and fetal images were saved initially in still,
print images, and later as digital images on CD-ROM and sent to the study office for review
by study investigators.
For analyses describing prevalence of leiomyomata, we adjusted for correlation within the
three study sites (North Carolina, Tennessee, and Texas) using generalized estimating
equations (22,23). For analyses of fibroid size we used the logarithm of the diameter for
normalization, and the geometric means are reported. Mixed models (24) were used to adjust
for correlations within study site when describing fibroid size among women with fibroids
present. Age-related changes in leiomyoma prevalence, multiplicity, and size were not
examined for Hispanics because of limited numbers. The χ2 test was used for comparing
categorical data on leiomyomata (type, location, and position) by ethnicity. We used two-
sided significance testing and considered p<0.05 statistically significant in presentation of
results. Data were analyzed with SAS 9.1 (SAS Institute, Cary, N.C.) and STATA10.0
(Stata Corporation, College Station, TX).
RESULTS
We enrolled 4,582 women of whom 4,271 had ultrasounds and were enrolled for the first
time (Table 1). Women who did not complete an ultrasound (n=311) were similar to those
who did in terms of maternal age, race/ethnicity, parity, marital status and education level.
Ultrasounds were completed an average of 61 days ±13 days from self-reported LMP.
Leiomyoma prevalence did not differ by gestational age at ultrasound (p=0.3).
The prevalence of one or more leiomyomata was 10.7% (95% confidence interval (CI): 8.5,
13.6). Among 458 women with one or more leiomyomata, we identified a total of 687
leiomyomata. Maximum leiomyoma diameter ranged from 0.5cm to 12.9cm. The mean size
of the women’s largest leiomyoma was 2.3cm (95% CI 1.8 to 2.8cm). Subserosal (42%) and
intramural (35%) leiomyomata were most common; 17% were submucous, and 5% were
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pedunculated. Nearly half of all leiomyomata occurred in the uterine corpus and 35% were
in the fundus. Leiomyomata were evenly distributed in anterior and posterior as well as on
the right and left sides of the uterus (p=0.2). Leiomyoma type and location did not differ
between blacks and whites (p≥0.1 for each comparison) except that black women had
slightly more leiomyomata in the posterior wall of the uterus than white women (p=0.03).
Seventy-two percent of women with a leiomyoma did not report a diagnosis of leiomyomata
prior to this pregnancy.
Although overall leiomyoma prevalence was 10.7%, prevalence differed by race/ethnicity.
Black women (n=915) had a prevalence of 18% (95% CI: 13, 25); white women (n= 2,826),
8% (95% CI: 7, 11); Hispanic women (n=335), 10% (95% CI: 5, 19); and the “other” group,
predominantly Asian (n=186), 13% (95% CI: 10, 16). Leiomyomata were present in women
as young as 19 years old. For black and white women we had sufficient numbers of
participants to examine differences with age. Prevalence among those under 25 years old
was 6% (95% CI: 3, 10) in black women and 4% (95%CI: 3, 7) in whites. Prevalence
increased with age for both blacks and whites (Figure 1). The rise in prevalence by age was
steeper among black women (p=0.02).
Among those with leiomyomata, having two or more leiomyomata also differed by race/
ethnicity: 39% of black women with leiomyomata had multiple tumors (95% CI: 37, 42),
20% of white women (95% CI: 20, 21), and 22% of Hispanic women (95% CI: 11, 42). The
presence of multiple tumors increased with age for black women from 22% (95% CI: 14,
35) for women younger than 30, to 58% (CI 52, 65) for women 35 years and older. For
white women, the proportion with multiple tumors increased slightly across age from 19%
(95% CI: 16, 22) in women younger than 30 to 25% (95% CI: 22, 29) for women 35 years
and older (Figure 2). This difference in the proportion of women with multiple tumors as
age advances was significantly different between blacks and whites (p=0.005).
Average size of the women’s largest leiomyoma differed by race/ethnicity as well. Average
size was 2.5cm (95% CI: 2.1, 3.1) for black women. This was not different from the average
leiomyoma size for Hispanics, 2.4cm, (95% CI: 1.8, 3.1), but significantly larger than
average leiomyoma size for white women, 2.0cm, (95% CI: 1.6, 2.4, p=0.0002). Leiomyoma
size tended to be larger in older compared with younger black women, but there was little
variation in size with age for whites. However, the difference between blacks and whites
was not statistically significant (p=0.08).
Prevalence estimates are intrinsically determined by the operational definition of the size of
a leiomyoma required to classify a mass as a leiomyoma. If we were to define prevalence
based on the original Muram criteria restricting leiomyoma diameter to ≥3.0cm, prevalence
is 7% in black (95% CI: 5, 10) and 3% in white women (95% CI: 2, 3), p<0.001. Another
common cut-point, requiring a diameter of ≥1.0cm, results in prevalence of 16% in black
(95% CI: 12, 22) and 7% in white women (95%CI: 6, 9), p<0.001.
DISCUSSION
We have estimated the prevalence of leiomyomata in pregnancy by uniformly screening
women during the first trimester. Our findings indicate a higher prevalence than previously
reported. These higher estimates are more compatible with those required to reach the
prevalence documented in imaging studies of older, non-pregnant women. We have
confirmed that leiomyomata are common and occur with increasing frequency with
advancing age.
Our data on race/ethnicity, in a younger population than those previously screened for
leiomyomata, are consistent with prior reports. We found that black women are more likely
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to have leiomyomata and to have more numerous and larger leiomyomata. Hispanic women
appeared to have leiomyoma characteristics similar to those of white women; however,
screening of larger groups of Hispanic women will be required.
The majority of our participants were unaware of their leiomyoma status prior to the study
ultrasound. Thus, we do not believe the sample was biased by a predominance of women
with leiomyomata seeking participation. However, due to the nature of this cohort with
predominantly planned pregnancies, we were not surprised that the participants were older,
more educated, less likely to smoke and more likely to be married than the general
population (25). Because our participants were pregnant, our cohort is limited to fertile
women. Leiomyomata may be associated with impaired fertility (7). If so, our findings
would underestimate the true prevalence in this age group. Leiomyomata might also be
related to pregnancy loss. If so, this too will result in an underestimate of tumor prevalence
because those with a loss prior to their scheduled ultrasound were invited to have
ultrasounds only in the last few years of data collection and those invited were less likely to
keep post-loss ultrasound appointments than their pregnant counterparts. The current dataset
includes only 56 of these women.
In 1970, the median age of women who gave birth in the United States was 25.4; in 2000 it
was 27.1 (26). This shift in the demographics of maternity makes a more nuanced
understanding of leiomyomata in pregnancy of increasing importance because larger
proportions of women and their pregnancies are affected. We lack knowledge about the
precise relationship of leiomyomata to adverse pregnancy outcomes and the risks and
benefits of leiomyoma intervention in reproductive women (10). Additionally, black women
experience a disproportionate share of pregnancy complications; and potentially as a result
of the higher prevalence and larger leiomyomata, they also have increased likelihood of
surgical interventions for leiomyomata. To provide the best informed care, the research
community must continue to pursue an understanding of the degree to which racial and
ethnic differences in prevalence of leiomyomata contribute to disparities in events like
miscarriage and prematurity. If leiomyomata do increase adverse pregnancy outcomes,
determining which interventions to use in the treatment of leiomyomata may reduce poor
outcomes and help mitigate disparities.
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Figure 1. Prevalence of Uterine Leiomyomas among Black (n=915) and White Women
(n=2826)*†
*Prevalence is for 2-year age intervals (18= 17 and 18 year olds, 20= 19 and 20 year olds,
etc).
†Sample size was too small for evaluation of prevalence by age in other race/ethnic
categories because there were fewer than five participants per cell in some cells.
Laughlin et al. Page 8













Figure 2. Percentage of Women with More Than One Leiomyoma among Those with
Leiomyomas
†Sample size was too small for evaluation of prevalence by age in other race/ethnic
categories because there were fewer than five participants per cell in some cells.
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Table 1
Characteristics of First Trimester Cohort Screened by Ultrasound for Uterine Leiomyomas
Black† White Hispanic‡
N 915 (21%) 2826 (66%) 335 (8%)
Mean age 26.1 (SD 5.6) 29.8 (SD 4.8) 27.0 (SD 5.5)
Age groups n (%) n (%) n (%)
17-24 423 (46) 360 (13) 124 (37)
25-29 243 (27) 993 (35) 108 (32)
30-34 169 (18) 1007 (36) 67 (20)
≥35 80 (9) 466 (17) 34 (10)
Missing 2
Parity
0 379 (45) 1293 (48) 130 (42)
1 253 (30) 992 (37) 107 (35)
2+ 208 (25) 425 (16) 69 (23)
Missing§ 75 116 29
BMI
Underweight(<20) 58 (6) 303 (11) 20 (7)
Normal weight (20-24.9) 238 (27) 1465 (52) 122 (40)
Overweight (25-29.9) 253 (28) 620 (22) 87 (29)
Obese (≥30) 344 (39) 407 (15) 73 (24)
Missing 22 31 33
Education
High school 375 (41) 311 (11) 159 (47)
Some college 267 (29) 432 (15) 75 (22)
≥4 years of college 273 (30) 2082 (74) 101 (30)
Missing 0 1 0
Marital Status
Married/co-habiting 574 (63) 2672 (95) 285 (85)
Other 341 (37) 154 (5) 50 (15)
Smoking
Never 686 (78) 1906 (70) 249 (79)
Past 148 (17) 696 (26) 59 (19)
Current 43 (5) 117 (4) 8 (3)
Missing‡ 38 107 19
*
Ethnicity other than black, white or Hispanic included Asian, Native American, and other (n=190).
†
p<0.001 for all comparisons of black and white women.
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‡
p<0.01 for comparisons of Hispanic and white women; p<0.05 for comparisons of Hispanic and black women except for parity and smoking
(non-significant).
§
The majority of missing data include women who completed the early pregnancy ultrasound but not the first trimester interview (n=161).
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